SLS BIO Co., Ltd (KOSDAQ:246250)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,969.00
+85.00 (4.51%)
At close: Jun 9, 2025

SLS BIO Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2015
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '15
Cash & Equivalents
1,835278.491,1441,8221,527464.33
Short-Term Investments
-3,0466,5367,5331,0211,502
Cash & Short-Term Investments
1,8353,3247,6809,3552,5481,966
Cash Growth
-72.67%-56.72%-17.90%267.16%29.58%2514.23%
Accounts Receivable
1,224616.711,7861,9823,0293,004
Other Receivables
35.9968.4746.0666.785.3510.55
Receivables
1,260685.181,8332,0493,0343,023
Inventory
172.02172.02173.37260.85307.2-
Prepaid Expenses
3.6323.3456.4757.193.221.78
Other Current Assets
51.17309.9946.4728.67166.0388.93
Total Current Assets
3,3234,5159,78911,7516,0585,080
Property, Plant & Equipment
4,0974,3904,7404,1734,0841,417
Long-Term Investments
6.97---42.1464.12
Other Intangible Assets
148.81149.42156.16251.83165.7852.02
Long-Term Accounts Receivable
-0-00-0123.780
Long-Term Deferred Tax Assets
1,6671,6831,2141,237849.52351.41
Long-Term Deferred Charges
-----3,797
Other Long-Term Assets
479.39492.14459.74425.37429.66245.33
Total Assets
9,72211,22916,35917,83811,75311,007

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2015
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '15
Accounts Payable
262.41165.05408.84693.41353.82320.4
Accrued Expenses
70.7551.8477.7467.86193.7970.25
Short-Term Debt
470----2,522
Current Portion of Long-Term Debt
-----37.76
Current Portion of Leases
558.68626.66561.43568.26565.64121.64
Current Income Taxes Payable
-----0.42
Other Current Liabilities
1,045740.46426.44406.21930.14949.51
Total Current Liabilities
2,4071,5841,4741,7362,0434,022
Long-Term Debt
-----1,357
Long-Term Leases
407.59686.911,1491,5361,95172.49
Pension & Post-Retirement Benefits
968.831,1541,1411,021977.72574.16
Other Long-Term Liabilities
159.22169.1281.5678.5275.260
Total Liabilities
3,9423,5943,8454,3715,0486,025

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2015
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '15
Common Stock
7,6747,6747,6743,8373,4332,889
Additional Paid-In Capital
1,2901,2901,2905,155201.83,137
Retained Earnings
-2,554-642.564,2614,3092,884-997.37
Treasury Stock
-899.88-899.88-899.88---
Comprehensive Income & Other
269.73213.35187.61164.95186.67-46.97
Shareholders' Equity
5,7807,63512,51313,4666,7054,982
Total Liabilities & Equity
9,72211,22916,35917,83811,75311,007

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2015
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '15
Total Debt
1,4361,3141,7102,1052,5174,111
Net Cash (Debt)
399.162,0105,9707,25030.98-2,144
Net Cash Growth
-92.20%-66.33%-17.66%23304.74%--
Net Cash Per Share
26.56133.60391.34515.694.52-430.00
Filing Date Shares Outstanding
15.0515.0515.0515.356.814.99
Total Common Shares Outstanding
15.0515.0515.0515.356.814.99
Working Capital
916.032,9318,31510,0154,0151,058
Book Value Per Share
384.07507.38831.55877.38983.97998.93
Tangible Book Value
5,6317,48612,35713,2146,5394,930
Tangible Book Value Per Share
374.18497.45821.17860.97959.64988.50
Machinery
8,7122,6132,6592,5862,501638.3
Construction In Progress
-50.49749.57113.6171.1770.72